CE Mark Notified Body Services

Not every device requires Notified Body involvement, but many do under EU MDR. Class I non-sterile, non-measuring devices may be self-declared, while higher-risk devices, sterile devices, measuring devices, and many reusable surgical instruments typically require review by a designated Notified Body. The correct answer depends on device classification, intended use, and conformity assessment route.

A CE Notified Body is an independent organization designated by an EU member state to assess whether certain products meet applicable European regulatory requirements. For medical devices under EU MDR, Notified Bodies review technical documentation, audit quality systems, and issue certificates when conformity is demonstrated. They play a formal role in market access for many device classes.

Most reviews require a structured technical documentation package aligned with EU MDR Annex II and III. That usually includes device description, intended use, classification rationale, GSPR checklist, risk management file, verification and validation evidence, clinical evaluation, labeling, IFU, PMS documentation, and relevant QMS records. The exact depth depends on device class, technology, and claims.

A submission-ready file is complete, internally consistent, traceable, and aligned to the exact EU MDR requirements your device will be assessed against. Readiness means your clinical evidence supports claims, risk management links to GSPR conformity, labeling matches intended use, and post-market obligations are addressed. A structured readiness assessment is the most reliable way to identify gaps before formal review.

Timelines vary based on device class, documentation maturity, remediation needs, and Notified Body capacity. Well-prepared submissions move faster because they reduce deficiency cycles and follow-up questions. In practice, the process often includes classification review, documentation preparation, internal gap closure, formal submission, audit activity where applicable, and response rounds before certification is issued.

Yes. Transition support typically includes reviewing legacy documentation against EU MDR requirements, identifying gaps in clinical evidence, PMS, PMCF, labeling, and technical documentation structure, then building a prioritized remediation plan. This is especially important because EU MDR expectations are broader and more rigorous than MDD, particularly around clinical justification, traceability, and post-market systems.

Deficiencies are formal requests for clarification, correction, or additional evidence. A strong response addresses each point directly, cites the relevant documentation, and closes the underlying compliance issue rather than offering vague explanations. Effective deficiency management often involves updating technical documents, strengthening evidence, improving traceability, and ensuring consistency across the entire submission package.

Yes. CE marking is not a one-time event, and manufacturers must manage changes, surveillance obligations, PMS outputs, and documentation updates throughout the product lifecycle. Ongoing support can include change impact assessments, CER updates, PMCF reviews, labeling revisions, complaint and PMS governance, and maintaining alignment between the technical file and the marketed device.